Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
CLEARONE INC received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).
- Exchange
- nasdaq
- Notice
- deficiency notice
- Rules
- 5620(a), 5810(c)(2)(G)
Exact text from the filing
January 10, 2025, the Company received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) informing the Company that because the Company did not hold an
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.9
CLEARONE INC received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).
- Exchange
- nasdaq
- Notice
- deficiency notice
- Rules
- 5620(a), 5810(c)(2)(G)
Exact text from the filing
January 10, 2025, the Company received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) informing the Company that because the Company did not hold an annual meeting of stockholders in 2024, the Company is not in compliance with the requirement to conduct an annual meeting of stockholders no later than one year after the end of its fiscal year, as set forth in Nasdaq Marketplace Rule 5620(a) (the “Annual Meeting Requirement”). In accordance with Nasdaq Marketplace Rule 5810(c)(2)(G), the Company has a period of 45 calendar d
View on SEC.gov